National Vision Holdings, Inc.
EYE$1.30B
Small CapNASDAQOphthalmic Goods🇺🇸North AmericaDULUTH
Drugs in Pipeline
3
Phase 3 Programs
3
Upcoming Catalysts
1
Next Catalyst
Aug 5, 2026
6wMarket Overview
Stock performance and key metrics
EYE News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
Inactivated SARS-CoV-2 Vaccine (Vero cell)
COVID-19
Diphtheria,Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed
Whooping Cough
SARS-CoV-2 Vaccine (Vero Cell), Inactivated
COVID-19 Pneumonia
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Inactivated SARS-CoV-2 Vaccine (Vero cell) | Phase 3 | COVID-19 | - | - |
Diphtheria,Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed | Phase 3 | Whooping Cough | - | - |
SARS-CoV-2 Vaccine (Vero Cell), Inactivated | Phase 3 | COVID-19 Pneumonia | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply